U.S. Biotechs Line Up to List in Korea Amid Jump in Share Prices

(Bloomberg) -- U.S. biotech firms are queuing up to list in South Korea, tempted by the promise of strong valuations amid a welcoming base of investors.

Bloomberg Quint

Add BloombergQuint App to Home screen.